LONDON, Dec 5 (Reuters) - GlaxoSmithKline said onMonday that Dominique Limet would step down at the end of March2017 as head of the drugmaker's majority-owned HIV business ViiVHealthcare, to be replaced by GSK insider Deborah Waterhouse.
Waterhouse, currently in charge of primary care within GSK'sU.S. pharmaceuticals operation, will take over as ViiV chiefexecutive at the same time as Emma Walmsley takes the helm ofthe wider GSK group.
Limet has led ViiV for the past seven years. In recent timessales have grown strongly on the back of new HIV medicines.Pfizer and Shionogi are minority shareholdersin ViiV. (Reporting by Ben Hirschler; Editing by Ruth Pitchford)